Cough and cold medication adverse events after market withdrawal and labeling revision

Pediatrics

Volumn 132, Issue 6, 2013, Pages 1047-1054

  Hampton, Lee M ^a   Nguyen, Duc B ^a,b   Edwards, Jonathan R ^a   Budnitz, Daniel S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Epidemic Intelligence Service Scientific Education and Professional Development Program Office   (Georgia)

Author keywords

Adverse events; Antitussive agents; Drug packaging; Drug safety; Medication errors; Nasal decongestants Expectorants; Nnprescription drugs; Poisoning; Product withdrawals

Indexed keywords

ANTITUSSIVE AGENT; NON PRESCRIPTION DRUG; DECONGESTIVE AGENT; EXPECTORANT AGENT;

ARTICLE; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; DRUG LABELING; DRUG MARKETING; DRUG RECALL; DRUG SAFETY; EMERGENCY WARD; FEMALE; HEALTH EDUCATION; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH; SCHOOL CHILD; TREND STUDY; UNSPECIFIED SIDE EFFECT; DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EMERGENCY HEALTH SERVICE; INFANT; NEWBORN; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTITUSSIVE AGENTS; CHILD; CHILD, PRESCHOOL; DRUG LABELING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EMERGENCY SERVICE, HOSPITAL; EXPECTORANTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NASAL DECONGESTANTS; NONPRESCRIPTION DRUGS; SAFETY-BASED DRUG WITHDRAWALS; UNITED STATES;

EID: 84890594938     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-2236     Document Type: Article

References (36)

1. Shehab N, Schaefer MK, Kegler SR, Budnitz DS. Adverse events from cough and cold medications after a market withdrawal of products labeled for infants. Pediatrics. 2010;126(6):1100-1107
2. Consumer Healthcare Products Association. Makers of OTC cough and cold medicines announce voluntary withdrawal of oral infant medicines. Available at: www. chpa-info.org/10-11-07-OralInfantMedicines. aspx. Accessed June 7, 2013
3. Harris G. Manufacturers remove drugs for infant cold. New York Times. October 12, 2007
4. Iwata E. Kids' cough, cold medicines pulled. USA Today. October 14, 2007
5. Gunn VL, Taha SH, Liebelt EL, Serwint Jr. Toxicity of over-the-counter cough and cold medications. Pediatrics. 2001;108(3).Available at: www.pediatrics.org/cgi/content/ full/108/3/e52
6. Food and Drug Administration. Nonprescription Drug Advisory Committee Meeting - cold, cough, allergy, bronchodilator, antiasthmatic drug products for over-thecounter human use, October 18 and 19, 2007. Available at: www.fda.gov/ohrms/ ockets/ac/07/briefing/2007-4323b1-02-FDA. pdf. Accessed May 3, 2010
7. Sharfstein JM, North M, Serwint Jr. Over the counter but no longer under the radar - pediatric cough and cold medications. N Engl J Med. 2007;357(23):2321-2324
8. Centers for Disease Control and Prevention. Infant deaths associated with cough and cold medications - two states, 2005. MMWR Morb Mortal Wkly Rep. 2007; 56(1):1-4
9. Food and Drug Administration. News & Events - FDA releases recommendations regarding use of over-the-counter cough and cold products. Products should not be used in children under 2 years of age; evaluation continues in older populations. Available at: www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/2008/ucm116839.htm. Accessed April 16, 2013
10. Klein-Schwartz W, Sorkin JD, Doyon S. Impact of the voluntary withdrawal of overthe- counter cough and cold medications on pediatric ingestions reported to poison centers. Pharmacoepidemiol Drug Saf. 2010;19(8):819-824
11. Consumer Healthcare Product Association. Statement from CHPA on the voluntary abel updates to oral OTC children's cough and cold medicines. Available at: www.chpainfo. org/10-07-08-pedcc.aspx. Accessed June 7, 2013
12. Food and Drug Administration. FDA statement following CHPA's announcement on nonprescription over-the-counter cough and cold medicines in children. Available at: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116964. htm. Accessed June 7, 2013
13. Harris G. Child warning added to cold remedies. New York Times. October 7, 2008
14. Food and Drug Administration. For Consumers - using over-the-counter cough and cold products in children. Available at: www.fda. gov/ForConsumers/ ConsumerUpdates/ ucm048515.htm. Accessed June 27, 2013
15. American Academy of Pediatrics. Coughs and colds: medicines or home remedies? Available at: www.healthychildren.org/English/ tips-tools/symptom- checker/Pages/Coughsand- Colds-Medicines-or-Home-Remedies.aspx. Accessed May 7, 2013
16. Consumer Healthcare Products Association. Children's OTC cough and cold medicines. Available at: www.chpa-info.org/issues/Childrens-CC-Overview.aspx. Accessed June 27, 2013
17. Forrester MB. Effect of cough and cold medication withdrawal and warning on ingestions by young children reported to Texas poison centers. Pediatr Emerg Care. 2012;28(6):510-513
18. Spiller HA, Beuhler MC, Ryan ML, Borys DJ, Aleguas A, Bosse GM. Evaluation of changes in poisoning in young children: 2000 to 2010. Pediatr Emerg Care. 2013;29(5):635-640
19. Mazer-Amirshahi M, Reid N, van den Anker J, Litovitz T. Effect of cough and cold medication restriction and label changes on pediatric ingestions reported to United States poison centers [published online ahead of print June 12, 2013]. J Pediatr. doi:10.1016/j.jpeds.2013.04.054doi:10.1016/j. jpeds.2013.04.054
20. C.S. Mott Children's Hospital. National Poll on Children's Health: despite warnings, parents continue to use cough and cold medicines for young kids. Available at: http:// mottnpch.org/reports-surveys/despitewarnings- parents-continue-use-cough- coldmedicines- young-kids. Accessed May 7, 2013
21. C.S. Mott Children's Hospital. National Poll on Children's Health: Parents ignore warning labels, give cough and cold meds to young kids. Available at: Ttp://mottnpch. org/reports-surveys/parents-ignore-warninglabels- give-cough-cold- meds-young-kids. Accessed May 7, 2013
22. Varney SM, Bebarta VS, Pitotti RL, Vargas TE. Survey in the emergency department of parents' understanding of cough and cold medication use in children younger than 2 years. Pediatr Emerg Care. 2012;28(9):883- 885
23. Lazarus SG, Lanski SL, Smith AS, Simon HK. Cold preparation use in young children after FDA warnings: do concerns still exist? Clin Pediatr (Phila). 2013;52(6):534-539
24. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296(15):1858-1866
25. Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System- Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES). Med Care. 2007;45(10 suppl 2):S96-S102
26. Wagner AK, Soumerai SB, Zhang F, Ross- Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309
27. American Academy of Pediatrics. Choosing Wisely campaign - AAP identifies lists of commonly sed tests and treatments to question. Available at: www.aap.org/en- us/aboutthe- aap/aap-press-room/pages/Choosing- Wisely-Campaign.aspx. Accessed May 7, 2013
28. Budnitz DS, Lovegrove MC. The last mile: Taking the final steps in preventing ediatric pharmaceutical poisonings. J Pediatr. 2012;160(2):190-192
29. Lovegrove MC, Hon S, Geller RG, et al. Efficacy of flow restrictors in limiting access of liquid medicines by young children. J Pediatr. 2013;163(4):1134-1139.e1
30. American Association of Poison Control Centers. Prevention. Available at: www. aapcc.org/prevention. Accessed June 18, 2013
31. Safe Kids Worldwide. Medication safety. Available at: www.safekids.org/medicinesafety. Accessed June 18, 2013
32. PROTECT Initiative. Up and away. Available at: www.upandaway.org. Accessed April 16, 2013
33. Ostroff C, Lee CE, McMeekin J. Unapproved prescription cough, cold, and allergy drug products: Recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications. Chest.2011;140(2):295-300
34. Doyon S, Tra Y, Klein-Schwartz W. Decrease in therapeutic errors involving prescription cough and cold medications in young children.J Pediatr Pharmacol Ther. 2012;17(1):84-87
35. Lovegrove MC, Shehab N, Hales CM, Poneleit K, Crane E, Budnitz DS. Emergency department visits for antiviral adverse events during the 2009 H1N1 influenza pandemic. Public Health Rep. 2011;126(3):312-317
36. Armstrong GL, Brammer L, Finelli L. Timely assessment of the severity of the 2009 H1N1 influenza pandemic. Clin Infect Dis. 2011;52(suppl 1):S83-S89